![Diane Mellett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ms. Diane Mellett is an Independent Director at Circio Holding ASA. She is on the Board of Directors at Circio Holding ASA. Ms. Mellett was previously employed as a Chief Business Officer & General Counsel by Affitech A/S and a General Counsel by Cambridge Antibody Technology Ltd. She also served on the board at BioXpress Therapeutics SA.
Actieve functies van Diane Mellett
| Bedrijven | Functie | Begin |
|---|---|---|
| CIRCIO HOLDING ASA | Directeur/Bestuurslid | 14-09-2015 |
Eerdere bekende functies van Diane Mellett
| Bedrijven | Functie | Einde |
|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Algemeen Adviseur | 30-06-2006 |
BioXpress Therapeutics SA
 BioXpress Therapeutics SA BiotechnologyHealth Technology Provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity | Directeur/Bestuurslid | - |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Directeur/Bestuurslid | 27-05-2010 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
40
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
BioXpress Therapeutics SA
BioXpress Therapeutics SA BiotechnologyHealth Technology Provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity | Health Technology |
